U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Cervical Adenocarcinoma

MedGen UID:
1615366
•Concept ID:
C4526859
•
Neoplastic Process
Synonym: Relapsed Cervical Adenocarcinoma

Definition

The reemergence of cervical adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Cervical Adenocarcinoma

Professional guidelines

PubMed

Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.
Gadducci A, Guerrieri ME, Cosio S
Crit Rev Oncol Hematol 2019 Mar;135:103-114. Epub 2019 Jan 19 doi: 10.1016/j.critrevonc.2019.01.006. PMID: 30819439
The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A, Tana R, Cosio S, Genazzani AR
Crit Rev Oncol Hematol 2008 Apr;66(1):10-20. Epub 2007 Oct 26 doi: 10.1016/j.critrevonc.2007.09.002. PMID: 17964182

Recent clinical studies

Etiology

The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A, Tana R, Cosio S, Genazzani AR
Crit Rev Oncol Hematol 2008 Apr;66(1):10-20. Epub 2007 Oct 26 doi: 10.1016/j.critrevonc.2007.09.002. PMID: 17964182
Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
Gadducci A, Tana R, Fanucchi A, Genazzani AR
Gynecol Oncol 2007 Oct;107(1 Suppl 1):S23-6. Epub 2007 Aug 28 doi: 10.1016/j.ygyno.2007.07.033. PMID: 17727924
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
Umesaki N, Izumi R, Fushiki H, Hasegawa K, Kono I, Nishida M, Noguchi H, Okuda H, Sugimori H, Takizawa K, Udagawa Y, Yamamoto K, Tanaka T, Noda K
Gynecol Oncol 1999 Oct;75(1):142-4. doi: 10.1006/gyno.1999.5556. PMID: 10502441

Diagnosis

En bloc resection of cervical adenocarcinoma with late recurrence to the iliopsoas.
Manlubatan SIT, Lopez MPJ, Garcia CMH, Gaston CLL
BMJ Case Rep 2021 Feb 18;14(2) doi: 10.1136/bcr-2020-239466. PMID: 33602768Free PMC Article
Disease-free survival after robotic-assisted laparoscopic total pelvic exenteration for recurrent cervical adenocarcinoma: A case report.
Yang Q, Tang J, Xiao L
Medicine (Baltimore) 2018 Jul;97(30):e11611. doi: 10.1097/MD.0000000000011611. PMID: 30045297Free PMC Article
The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A, Tana R, Cosio S, Genazzani AR
Crit Rev Oncol Hematol 2008 Apr;66(1):10-20. Epub 2007 Oct 26 doi: 10.1016/j.critrevonc.2007.09.002. PMID: 17964182
Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
Gadducci A, Tana R, Fanucchi A, Genazzani AR
Gynecol Oncol 2007 Oct;107(1 Suppl 1):S23-6. Epub 2007 Aug 28 doi: 10.1016/j.ygyno.2007.07.033. PMID: 17727924
Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
Tabata T, Takeshima N, Tanaka N, Hirai Y, Hasumi K
Tumour Biol 2000 Nov-Dec;21(6):375-80. doi: 10.1159/000030143. PMID: 11006578

Therapy

Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.
Gadducci A, Guerrieri ME, Cosio S
Crit Rev Oncol Hematol 2019 Mar;135:103-114. Epub 2019 Jan 19 doi: 10.1016/j.critrevonc.2019.01.006. PMID: 30819439
Treatment of recurrent cervical adenocarcinoma with BMS-247550, an epothilone B analog.
Agrawal M, Edgerly M, Fojo T, Kotz H
Gynecol Oncol 2003 Jul;90(1):96-9. doi: 10.1016/s0090-8258(03)00146-x. PMID: 12821348
Remission of metastatic cervical adenocarcinoma with weekly paclitaxel.
Ota S, Sugiyama T, Ushijima K, Fujiyoshi K, Komai K, Hirai N, Nishida T, Kamura T
Int J Gynecol Cancer 2001 Mar-Apr;11(2):167-8. doi: 10.1046/j.1525-1438.2001.011002167.x. PMID: 11328417
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
Umesaki N, Izumi R, Fushiki H, Hasegawa K, Kono I, Nishida M, Noguchi H, Okuda H, Sugimori H, Takizawa K, Udagawa Y, Yamamoto K, Tanaka T, Noda K
Gynecol Oncol 1999 Oct;75(1):142-4. doi: 10.1006/gyno.1999.5556. PMID: 10502441

Prognosis

Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.
Gadducci A, Guerrieri ME, Cosio S
Crit Rev Oncol Hematol 2019 Mar;135:103-114. Epub 2019 Jan 19 doi: 10.1016/j.critrevonc.2019.01.006. PMID: 30819439
The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A, Tana R, Cosio S, Genazzani AR
Crit Rev Oncol Hematol 2008 Apr;66(1):10-20. Epub 2007 Oct 26 doi: 10.1016/j.critrevonc.2007.09.002. PMID: 17964182
Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
Gadducci A, Tana R, Fanucchi A, Genazzani AR
Gynecol Oncol 2007 Oct;107(1 Suppl 1):S23-6. Epub 2007 Aug 28 doi: 10.1016/j.ygyno.2007.07.033. PMID: 17727924

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...